中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
35期
31-31,32
,共2页
小儿支原体肺炎%阿奇霉素%孟鲁司特%疗效
小兒支原體肺炎%阿奇黴素%孟魯司特%療效
소인지원체폐염%아기매소%맹로사특%료효
Children’s mycoplasma pneumonia%Azithromycin%Montelukast%Curative effect
目的:为了能够更快的改善小儿支原体肺炎临床症状和提高的治疗效果,分析和研究在阿奇霉素及对症治疗的基础上加用孟鲁司特的可行性和价值。方法采取随机数字表的方法将来我院儿科就诊的98例小儿支原体肺炎患者分为观察组和对照组,其中对照组患儿治疗上给予抗感染、支持对症治疗,而观察组患者在对照组的治疗的基础上加用孟鲁司特治疗,统计和分析两组患者的症状改善情况。结果经过对研究数据分析发现,对照组患儿的症状改善情况明显不如观察组患儿的,且两组比较差异具有统计学意义(P<0.05)。结论小儿支原体肺炎在阿奇霉素及对症治疗基础上加用孟鲁司特,这样不仅提高疗效,更有利于患儿症状缓解,值得推荐和应用。
目的:為瞭能夠更快的改善小兒支原體肺炎臨床癥狀和提高的治療效果,分析和研究在阿奇黴素及對癥治療的基礎上加用孟魯司特的可行性和價值。方法採取隨機數字錶的方法將來我院兒科就診的98例小兒支原體肺炎患者分為觀察組和對照組,其中對照組患兒治療上給予抗感染、支持對癥治療,而觀察組患者在對照組的治療的基礎上加用孟魯司特治療,統計和分析兩組患者的癥狀改善情況。結果經過對研究數據分析髮現,對照組患兒的癥狀改善情況明顯不如觀察組患兒的,且兩組比較差異具有統計學意義(P<0.05)。結論小兒支原體肺炎在阿奇黴素及對癥治療基礎上加用孟魯司特,這樣不僅提高療效,更有利于患兒癥狀緩解,值得推薦和應用。
목적:위료능구경쾌적개선소인지원체폐염림상증상화제고적치료효과,분석화연구재아기매소급대증치료적기출상가용맹로사특적가행성화개치。방법채취수궤수자표적방법장래아원인과취진적98례소인지원체폐염환자분위관찰조화대조조,기중대조조환인치료상급여항감염、지지대증치료,이관찰조환자재대조조적치료적기출상가용맹로사특치료,통계화분석량조환자적증상개선정황。결과경과대연구수거분석발현,대조조환인적증상개선정황명현불여관찰조환인적,차량조비교차이구유통계학의의(P<0.05)。결론소인지원체폐염재아기매소급대증치료기출상가용맹로사특,저양불부제고료효,경유리우환인증상완해,치득추천화응용。
Objective??In?order?to?improve?the?clinical?symptoms?of?mycoplasma?pneumonia?in?children?more?quickly?and?improve?the?treatment?effect,?to analyze and research the feasibility and value added by montelukast based on given azithromycin and symptomatic.Methods??Divided?98?cases?of?mycoplasma?pneumonia?in?children?patients?in?pediatric?clinic?of?our?hospital?into?observation?group?and?control?group?adopt?the?method?of?random?number?table, the control group were treated with anti infection, lfuid infusion and symptomatic treatment, while the patients in the observation group received montelukast therapy based on the control group, counted and analyzed improvement of symptoms of the two groups.Results??Data?analysis?found?that,?improvement of symptoms of control group was signiifcantly less than the observation group, and the difference between the two groups was with statistical significance?(P<0.05).?Conclusion Azithromycin and symptomatic treatment combined with montelukast can improves the curative effect in treating children’s?mycoplasma?pneumonia,?and?do?more?conducive?to?children?with?symptomatic?relief,?worthy?of?recommendation?and?application.